文献
J-GLOBAL ID:202202226954419519
整理番号:22A0749925
全国コホート研究における血液学的新生物のエピジェネティクス関連リスク減少: ヒドララジンの菌血症および治療効果【JST・京大機械翻訳】
Epigenetics-Associated Risk Reduction of Hematologic Neoplasms in a Nationwide Cohort Study: The Chemopreventive and Therapeutic Efficacy of Hydralazine
著者 (15件):
Yang Bing-Heng
(1Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan)
,
Yang Bing-Heng
(2Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, Taipei, Taiwan)
,
Lin Wei-Zhi
(3Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan)
,
Lin Wei-Zhi
(4Fidelity Regulation Therapeutics Inc., Taoyuan City, Taiwan)
,
Chiang Yu-Ting
(5Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan)
,
Chen Yeu-Chin
(6Division of Hematology and Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan)
,
Chung Chi-Hsiang
(7School of Public Health, National Defense Medical Center, Taipei, Taiwan)
,
Chung Chi-Hsiang
(8Department of Medical Research, Tri-Service General Hospital, Taipei, Taiwan)
,
Chung Chi-Hsiang
(9Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan)
,
Chien Wu-Chien
(7School of Public Health, National Defense Medical Center, Taipei, Taiwan)
,
Chien Wu-Chien
(8Department of Medical Research, Tri-Service General Hospital, Taipei, Taiwan)
,
Chien Wu-Chien
(9Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan)
,
Shiau Chia-Yang
(1Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan)
,
Shiau Chia-Yang
(3Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan)
,
Shiau Chia-Yang
(4Fidelity Regulation Therapeutics Inc., Taoyuan City, Taiwan)
資料名:
Frontiers in Oncology (Web)
(Frontiers in Oncology (Web))
巻:
12
ページ:
809014
発行年:
2022年
JST資料番号:
U7089A
ISSN:
2234-943X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)